Goggin

5 International Real Estate ETFs in the Crosshairs

Risk should not be confused with volatility.

FDA Calendar Extreme Trades: 85 Single Digit Stocks

Keep and eye on GWP (GWPRF) for its application to the FDA for approval this fall or winter. On London's AIM.

Jazz and Transcept Pharmaceuticals on the Rise

GWPharamceutical, London AIM market, is in Phase III for cancer pain. The company is almost unknown in the US and has approvals for several indications in other countries.

Disclosure: I own some.

Rational Market Theory and Black Swans in Healthcare Reform

I have studied motivation for about half a century and know of no psychologist who says humans are fully rational. Most say we are basically irrational with a slight rational overlay.

Rational market theory is an unsupported assumption, not evidence based.

Pending Clinical Trial Results: Ten Extreme Trades

GW Pharmaceutical (GWPRF) is in a Phase III trial in the US for treating cancer pain with its marijuana-derived non-smoked drug Sativex. Very thinly traded in the US, it is on London's AIM market. Fascinating information on this use and others, some already approved internationally is at their website gwpharma.com.
Disclorsure: I own GWPRF.

Healthcare Reform, M&A Likely to Focus on Preventative Medicine

Take a look at G. W. Pharmaceutical traded in London: GWPRF

CEFs' Dismal 2008 Performance: Better Outlook for 2009

Joe, whoever you are, thanks for your analyses of CEFs. You are the only person I have on my Seeking Alpha Watchlist.

A retired guy, his wife, and dog.